Health Centers Sue HHS for Drug Discount Dispute Process (1)

Oct. 22, 2020, 4:19 PMUpdated: Oct. 22, 2020, 6:28 PM

Health centers have no remedy against pharmaceutical companies that they say are overcharging them for certain drugs because the government isn’t doing its regulatory duties, a community health-care association alleged in a lawsuit against the HHS.

The National Association of Community Health Centers wants the government to finalize a dispute resolution policy so facilities have a clear way to push back against drug companies, according to a complaint filed Wednesday in the U.S. District Court for the District of Columbia.

At the center of the lawsuit is a federal drug discount program called 340B that mandates drugmakers offer steep discounts ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.